Literature DB >> 350385

1,2-dihydro-1,2-dihydroxy-5-methylchrysene, a major activated metabolite of the environmental carcinogen 5-methylchrysene.

S S Hecht, E LaVoie, R Mazzarese, S Amin, V Bedenko, D Hoffmann.   

Abstract

The metabolic activation of the environmental carcinogen 5-methylchrysene was studied by combining high-pressure liquid chromatographic analysis of metabolites formed in vitro with assays of these metabolites for mutagenic activity toward Salmonella typhimurium. Metabolites were formed by incubation of 5-methylchrysene with the 9000 x g supernatant from Aroclor-treated rat livers. With the use of reverse-phase columns, the metabolites were resolved into nine peaks, A to I. Each peak was collected and tested for mutagenicity with activiation. Significant mutagenic activity was observed primarily in peak E and to a lesser extent in peak D. None of the other metabolites showed significant mutagenic activity. The major mutagenic metabolite (peak E) was identified as 1,2-dihydro-1,2-dihydroxy-5-methylchrysene (7.0% from 5-methylchrysene); Peak D was 7,8-dihydro-7,8-dihydroxy-5-methylchrysene (2.6% from 5-methylchrysene). Other metabolites included 9,10-dihydro-9,10-dihydroxy-5-methylchrysene, 9-hydroxy-5-methylchrysene, 7-hydroxy-5-methylchrysene, 1-hydroxy-5-methylchrysene, and 5-hydroxymethylchrysene. These results indicate that 1,2-dihydro-1,2-dihydroxy-5-methylchrysene is a major proximate mutagen of 5-methylchrysene.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350385

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

Review 1.  The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

Authors:  Ercole Cavalieri; Eleanor Rogan
Journal:  Mol Aspects Med       Date:  2013-08-30

2.  Metabolism of an Alkylated Polycyclic Aromatic Hydrocarbon 5-Methylchrysene in Human Hepatoma (HepG2) Cells.

Authors:  Meng Huang; Li Zhang; Clementina Mesaros; Linda C Hackfeld; Richard P Hodge; Ian A Blair; Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2015-10-05       Impact factor: 3.739

3.  Identification of four trans-3,4-dihydrodiol metabolites of 7,12-dimethylbenz[a]anthracene and their in vitro DNA-binding activities upon further metabolism.

Authors:  M W Chou; S K Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

4.  Cytotoxicity and mutagenicity of 5-methylchrysene and its 1,2-dihydrodiol in V79MZ cells modified to express human CYP1A1 or CYP1B1, in the presence or absence of human GSTP1 coexpression.

Authors:  Sarfaraz Ahmad; Sandra L Kabler; Lisa Rudd; Shantu Amin; Johannes Doehmer; Charles S Morrow; Alan J Townsend
Journal:  Toxicol Lett       Date:  2008-10-22       Impact factor: 4.372

Review 5.  Significance of various enzymes in the control of reactive metabolites.

Authors:  F Oesch
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

6.  Formation and persistence of benzo(a)pyrene metabolite-DNA adducts.

Authors:  S J Stowers; M W Anderson
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

Review 7.  Computer-assisted mechanistic structure-activity studies: application to diverse classes of chemical carcinogens.

Authors:  G H Loew; M Poulsen; E Kirkjian; J Ferrell; B S Sudhindra; M Rebagliati
Journal:  Environ Health Perspect       Date:  1985-09       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.